{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:28:17Z","timestamp":1788672497738,"version":"build-2803163510"},"reference-count":38,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2283,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1111\/j.1365-2710.2009.01046.x","type":"journal-article","created":{"date-parts":[[2009,4,16]],"date-time":"2009-04-16T02:03:02Z","timestamp":1239847382000},"page":"355-361","source":"Crossref","is-referenced-by-count":50,"title":["Genetic polymorphisms in folate pathway enzymes as a possible marker for predicting the outcome of methotrexate therapy in Japanese patients with rheumatoid arthritis"],"prefix":"10.1155","volume":"34","author":[{"given":"H.","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Fujimaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Daimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.7326\/0003-4819-103-4-489","article-title":"Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study","volume":"103","author":"Andersen","year":"1985","journal-title":"Annals of Internal Medicine"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJM199802193380803","article-title":"Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia","volume":"338","author":"Evans","year":"1998","journal-title":"The New England Journal of Medicine"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB3","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199610033351408","article-title":"Intrinsic and acquired resistance to methotrexate in acute leukemia","volume":"335","author":"Gorlick","year":"1996","journal-title":"The New England Journal of Medicine"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1470-2045(01)00516-2","article-title":"Childhood acute lymphoblastic leukaemia - current status and future perspectives","volume":"2","author":"Pui","year":"2001","journal-title":"The Lancet Oncology"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199808273390907","article-title":"Acute lymphoblastic leukemia","volume":"339","author":"Pui","year":"1998","journal-title":"The New England Journal of Medicine"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB6","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJM198503283121303","article-title":"Efficacy of low-dose methotrexate in rheumatoid arthritis","volume":"312","author":"Weinblatt","year":"1985","journal-title":"The New England Journal of Medicine"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/art.10148","article-title":"Guidelines for the management of rheumatoid arthritis: 2002 Update","volume":"46","author":"American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines.","year":"2002","journal-title":"Arthritis and Rheumatism"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0049-0172(98)80049-8","article-title":"Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity","volume":"27","author":"van Ede","year":"1998","journal-title":"Seminars in arthritis and rheumatism"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB9","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJM200011303432201","article-title":"A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis","volume":"343","author":"Bathon","year":"2000","journal-title":"The New England Journal of Medicine"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/rheumatology\/32.8.751","article-title":"Methotrexate - the relationship between dose and clinical effect","volume":"32","author":"Seideman","year":"1993","journal-title":"British Journal of Rheumatology"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB11","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1001\/archinte.159.21.2542","article-title":"Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group","volume":"159","author":"Strand","year":"1999","journal-title":"Archives of Internal Medicine"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB12","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1182\/blood.V100.10.3832","article-title":"Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia","volume":"100","author":"Laverdiere","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB13","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/sj.tpj.6500438","article-title":"Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis","volume":"7","author":"Drozdzik","year":"2007","journal-title":"The Pharmacogenomics Journal"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB14","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1016\/S0021-9258(18)91984-8","article-title":"Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell","volume":"243","author":"Goldman","year":"1968","journal-title":"Journal of Biological Chemistry"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0083-6729(08)60397-0","article-title":"Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism","volume":"45","author":"Shane","year":"1989","journal-title":"Vitamins and Hormones"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB16","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1038\/sj.onc.1206946","article-title":"Resistance to antifolates","volume":"22","author":"Zhao","year":"2003","journal-title":"Oncogene"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB17","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1365-2141.2000.02070.x","article-title":"Classification of ex vivo methotrexate resistance in acute lymphoblastic and myeloid leukaemia","volume":"110","author":"Rots","year":"2000","journal-title":"British Journal of Haematology"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB18","first-page":"2423","article-title":"Methotrexate intracellular disposition in acute lymphoblastic leukemia: a mathematical model of gamma-glutamyl hydrolase activity","volume":"8","author":"Panetta","year":"2002","journal-title":"Clinical Cancer Research"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB19","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0026-895X(24)13274-9","article-title":"Characterization of human cellular gamma-glutamyl hydrolase","volume":"53","author":"Rhee","year":"1998","journal-title":"Molecular Pharmacology"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-1119(03)00807-2","article-title":"Identification of single nucleotide polymorphisms in the human gamma-glutamyl hydrolase gene and characterization of promoter polymorphisms","volume":"319","author":"Chave","year":"2003","journal-title":"Gene"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.fpc.0000114761.78957.7e","article-title":"A substrate specific functional polymorphism of human gamma-glutamyl hydrolase alters catalytic activity and methotrexate polyglutamate accumulation in acute lymphoblastic leukaemia cells","volume":"14","author":"Cheng","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1248\/bpb.30.839","article-title":"Genetic polymorphism of C452T (T127I) in human gamma-glutamyl hydrolase in a Japanese population","volume":"30","author":"Hayashi","year":"2007","journal-title":"Biological and Pharmaceutical Bulletin"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00008571-200411000-00004","article-title":"Contribution of common polymorphisms in reduced folate carrier and gamma-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis","volume":"14","author":"Dervieux","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/blood.V98.1.231","article-title":"Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism","volume":"98","author":"Ulrich","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00008571-200204000-00002","article-title":"Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses","volume":"12","author":"Urano","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB26","first-page":"601","article-title":"The relationship between serial measures of disease activity and outcome in rheumatoid arthritis","volume":"86","author":"Hassell","year":"1993","journal-title":"The Quarterly Journal of Medicine"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB27","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/1529-0131(200007)43:7<1473::AID-ANR9>3.0.CO;2-N","article-title":"Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis","volume":"43","author":"Plant","year":"2000","journal-title":"Arthritis and Rheumatism"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB29","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/hrt.2003.020180","article-title":"Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study","volume":"90","author":"Souverein","year":"2004","journal-title":"Heart"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1096-7192(03)00086-6","article-title":"Evaluation of genetic variants in the reduced folate carrier and in glutamate carboxypeptidase II for spina bifida risk","volume":"79","author":"Morin","year":"2003","journal-title":"Molecular Genetics and Metabolism."},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB31","first-page":"3416","article-title":"Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G\/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers","volume":"7","author":"Whetstine","year":"2001","journal-title":"Clinical Cancer Research"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB32","doi-asserted-by":"crossref","first-page":"30855","DOI":"10.1074\/jbc.M003988200","article-title":"Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake","volume":"275","author":"Drori","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB33","doi-asserted-by":"crossref","first-page":"30189","DOI":"10.1074\/jbc.273.46.30189","article-title":"A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance","volume":"273","author":"Jansen","year":"1998","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB34","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1373\/49.10.1632","article-title":"HPLC determination of erythrocyte methotrexate polyglutamates after low-dose methotrexate therapy in patients with rheumatoid arthritis","volume":"49","author":"Dervieux","year":"2003","journal-title":"Clinical Chemistry"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0003-2697(76)80047-4","article-title":"A rapid, radiochemical-ligand binding assay for methotrexate","volume":"70","author":"Kamen","year":"1976","journal-title":"Analytical Biochemistry"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB36","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0076-6879(86)22191-6","article-title":"Analysis of methotrexate polyglutamate derivatives in vivo","volume":"122","author":"Kamen","year":"1986","journal-title":"Methods in Enzymology"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB37","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3109\/00365518509155274","article-title":"Enzymatic assay for methotrexate in erythrocytes","volume":"45","author":"Schroder","year":"1985","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"key":"10.1111\/j.1365-2710.2009.01046.x-BIB76","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3835(02)00060-5","article-title":"Multiplex PCR for simultaneous detection of 677 C\u2192T and 1298 A\u2192C polymorphisms in methylenetetrahydrofolate reductase gene for population studies of cancer risk","volume":"181","author":"Yi","year":"2002","journal-title":"Cancer Letters"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2710.2009.01046.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2710.2009.01046.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T23:54:21Z","timestamp":1739058861000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2710.2009.01046.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2710.2009.01046.x","relation":{},"ISSN":["0269-4727","1365-2710"],"issn-type":[{"value":"0269-4727","type":"print"},{"value":"1365-2710","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}